Results 221 to 230 of about 173,634 (281)

Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions

Clinical Endocrinology, EarlyView.
ABSTRACT Objective To provide clinicians involved in managing menopause with a summary of current evidence surrounding menopause hormone therapy (MHT). Design The authors evaluate and synthesize existing pooled evidence relating to MHT's clinical indications, efficacy, and safety and explore the limitations of existing data. Patients The review focuses
Annice Mukherjee, Susan R. Davis
wiley   +1 more source

Pilot Study of Daily Exemestane in Women with Endometrial Intraepithelial Neoplasia or Low-Grade Endometrial Cancer. [PDF]

Clin Cancer Res
Erickson BK, Bailey H, Arend RC, El-Rayes D, Khalifa MA, Skubitz A, Boylan K, Nelson AC, Burton A, Thyagarajan B, Havighurst T, Kim K, Dimond E, DeShong K, Heckman-Stoddard B, Samimi G, Szabo E, Barroilhet L.   +17 more
europepmc   +1 more source

Serum Estradiol Concentrations With Estradiol 0.06% Gel in Transgender and Gender‐Diverse Adults

Clinical Endocrinology, EarlyView.
ABSTRACT Objective Transgender and gender‐diverse individuals undergoing estradiol therapy for gender affirmation are typically treated with oral or transdermal estradiol, with transdermal estradiol recommended for those aged > 45 years. There are limited data evaluating estradiol gel in gender‐affirming hormone therapy regimens. We aimed to assess the
Raquel A. Maggacis, Ada S. Cheung, Brendan J. Nolan   +2 more
wiley   +1 more source

Modulation of lactose synthesis and orexinergic-glucose pathway by sex steroid hormones. [PDF]

Physiol Rep
Hakizimana JC, Alagbonsi AI.
europepmc   +1 more source

Lifestyle Management in Menopause: A Systematic Review of Women With Premature Ovarian Insufficiency

Clinical Endocrinology, EarlyView.
ABSTRACT Objective Premature ovarian insufficiency (POI), the loss of ovarian function before age 40, increases the risk of cardiovascular disease, low bone mineral density, dementia and psychological distress. Lifestyle interventions reduce chronic disease risk in other populations and, with hormone therapy, may improve health outcomes in POI.
Ladan Yeganeh, Nathalie Vermeulen, Carolyn Ee, Helena Teede, Amanda J. Vincent   +4 more
wiley   +1 more source

Cardiovascular Health in Women—Across the Lifespan

Clinical Endocrinology, EarlyView.
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar, Jessica Yao, Simone Gong, Madhuka Wijayarathne, Monique Watts, Swati Mukherjee   +5 more
wiley   +1 more source

Is exercise duration more important than intensity in endometriosis? [PDF]

BMC Womens Health
Hartmann TE, Baker KA, Girard D.
europepmc   +1 more source

The Specific Effects of the Estradiol on the Aminoacid Dynamics in the Rabbit Uterine and Placental Tissue

, 1965
Yasuo Yoshimura
openalex   +1 more source

17β-Estradiol Promotes Right Ventricle Angiogenesis via Estrogen Receptor α and Apelin Signaling

Simon Bousseau, Andrea L. Frump, Avram Walts, Amanda Fisher, Bakhtiyor Yakubov, Steeve Provencher, Sandra Breuils‐Bonnet, Sébastien Bonnet, Tim Lahm   +8 more
openalex   +1 more source